Bacterial extracellular vesicles in biofluids as potential diagnostic biomarkers

• Main Authors: Su, Kar Yan, Koh Kok, Jie Yi, Chua, Yie Wei, Ong, Shearn Dior, Ser, Hooi Leng *, Priyia, Pusparajah, Saw, Pui San, Goh, Bey Hing *, Lee, Wai Leng
• Format: Article
• Published: Taylor and Francis Group 2022
• Subjects: QH Natural history; QR Microbiology; R Medicine (General)
• Online Access: http://eprints.sunway.edu.my/3003/; https://doi.org/10.1080/14737159.2022.2166403

Introduction: Extracellular vesicles (EVs) are spherical membrane-derived lipid bilayers released by cells. The human microbiota consists of trillions of microorganisms, with bacteria being the largest group secreting microbial EVs. The discovery of bacterial EVs (BEVs) has garnered interest among researchers as potential diagnostic markers, given that the microbiota is known to be associated with various diseases and EVs carry important macromolecular cargo for intercellular interaction. Areas covered: The differential bacterial composition identified from BEVs isolated from biofluids between patients and healthy controls may be valuable for detecting diseases. Therefore, BEVs may serve as novel diagnostic markers. Literature search on PubMed and Google Scholar databases was conducted. In this special report, we outline the commonly used approach for investigating BEVs in biofluids, the 16S ribosomal RNA gene sequencing of V3-V4 hypervariable regions, and the recent studies exploring the potential of BEVs as biomarkers for various diseases. Expert opinion: The emerging field of BEVs offers new possibilities for the diagnosis of various types of diseases, although there remain issues that need to be resolved in this research area to implement BEVs in clinical applications. Hence, it is important for future studies to take these challenges into consideration when investigating the diagnostic value of BEVs.